Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review

Immune checkpoint inhibitors (ICI) are widely used for the treatment of various malignant neoplasms. Interstitial lung disease is a well-known immune-related adverse event, however, ICI-induced airway disease remains under-recognized. Herein, we report two similar cases of pembrolizumab-induced trac...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seminars in oncology 2022-12, Vol.49 (6), p.439-455
Hauptverfasser:	Kawakami, Naoki, Saito, Hiroaki, Takahashi, Susumu, Kajie, Shinpei, Kato, Rina, Shimaya, Kazuhiro, Wakai, Yoko, Saito, Kazuhito, Sakashita, Mai
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Asthma Bronchiolitis Cough - drug therapy Humans Immune checkpoint inhibitor Immune Checkpoint Inhibitors - therapeutic use Immune-related adverse event Lung Neoplasms - drug therapy Pulmonary Disease, Chronic Obstructive - drug therapy Tracheobronchitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!